Skip to content

ESLA - Estrella Immunopharma, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchE

Estrella Immunopharma Inc.

ESLA · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

E

ESLAEstrella Immunopharma Inc.

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $3.15
52-wk low: $0.68
Prev close: $1.94
Mkt cap: $32.0M
Beta: 0.89
P/B: 4.1x

Smart money

6 funds hold a position and insiders have been net buying.

Real smart money

Funds holding this stock

6 holders

Combined position$328K

CI
Citadel
Ken Griffin · Q4 2025 13F
$100K
position
MW
Marshall Wace

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $32M

Valuation

P/B4.13

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: ESLA
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $32.05M
Beta: 0.89

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

-268.5%

Q4 2025 13F

$88K

position

JS

Jim Simons

Q2 2026 13F

$41K

position

3 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 3 holders

Coverage gaps for ESLA

No recent Congress trade
No recent market-voice mention

No earnings history on record for this stock yet.

The next reported quarter will appear here

Next report

What the street expects next

-268.5%

ROA-251.9%

Growth

Beta0.89